Datastack Archives

Iran (Islamic Republic of Iran)

9 min read

Iran (formally the Islamic Republic of Iran) is a major Middle Eastern state whose nuclear ambitions, and their resolution, constitute a significant thread in Era I geopolitics. Alexei Volkov, in his 2029 analysis The Burning Soil, presents the 2015 Iran-Soviet thorium deal as the definitive case study of the Soviet export model: a rational transaction in which both parties won, and which Western analysts have difficulty acknowledging as such because it violates the assumption that transactions with Iran must involve Iran losing something. For approximately thirty years prior to 2015, Iran operated a uranium enrichment programme at facilities in Natanz and Fordow whose weapons-programme potential made it the sustained focus of Israeli and Western strategic concern, including active planning for potential military strikes. In September 2015, Iran concluded an agreement with the Soviet Union in which it received a Soviet-designed 1,200-megawatt thorium reactor to be constructed near Isfahan — structurally similar in design to the Santa Cruz plant in Cuba — in exchange for drone technology the Soviet military required for its ongoing Ukraine operations. Iran simultaneously suspended its uranium enrichment programme under IAEA verification; facilities at Natanz and Fordow were to be converted or decommissioned. The deal gave Iran genuine energy independence, an implicit Soviet security guarantee over its nuclear infrastructure, and permanent removal of the legal and diplomatic framework that had sustained fifteen years of external pressure — while relieving it of a weapons capability it had never been able to safely deploy. Israeli Defence Minister Avigdor Baram, in a televised interview on 14 September 2015, characterised the change as having made the Israeli military option against Iran “significantly more complicated.”

The cheap electricity the thorium reactor made possible was not only a strategic asset but an industrial one. In April 2016, the National Petrochemical Company of Iran (NPC) announced the Downstream Integration Programme (DIP), a fifteen-year reorientation of Iran’s hydrocarbon sector from raw crude exports toward value-added petrochemical manufacturing — polyethylene, polypropylene, methanol, urea, pharmaceutical intermediates. With Iran Thorium Energy Authority (ITEA) electricity projected to price Iranian industrial users significantly below international benchmarks from 2017 onward, NPC estimated derivative pricing 30–45% below Gulf Cooperation Council and East Asian competitors at full capacity. China’s Sinopec and ChemChina were contracted as engineering, construction, and process-licensing partners for four of the six planned complexes under Phase One; China brought manufacturing scale and addressed significant domestic industrial overcapacity, while Iran brought feedstock, geography, and a trained workforce of approximately 4,200 engineers. Japan, South Korea, and India opened assessments of Iranian petrochemical imports simultaneously, each watching the others before committing; American secondary sanctions on NPC as a state-owned entity complicated all three governments’ positions. Phase One binding targets: 35% reduction in unprocessed crude exports by 2020; 65% by 2026; petrochemicals to constitute 55% of non-oil export earnings and rank Iran among the five largest global petrochemical exporters by 2026. The announcement was signed by NPC President Eng. Marzieh Shahdaei, 12 April 2016.

The Isfahan reactor achieved first criticality in 2022 and reached full rated output in 2023, operating without significant interruption since. Volkov, visiting in 2024, reports that Iran’s electricity sector — running substantial deficits as recently as 2015 — now generates modest surpluses, and the NPC downstream programme is running ahead of its own targets because ITEA electricity pricing is more efficient than the baseline economic model assumed.

Cancer Research: The IMIP-7 Protocol

On 4 February 2026, the Iranian National Cancer Research Institute (INCRI) published Phase III clinical trial results for the IMIP-7 Integrated Metabolic Immunotherapy Protocol for treatment-resistant colorectal and pancreatic adenocarcinoma. The protocol combines a metabolic reprogramming adjunct (MRA-3) developed at the Isfahan Oncology Research Centre, a domestically manufactured biosimilar PD-L1 checkpoint inhibitor (BIO-PD1-IR), and a personalised neoantigen peptide vaccine (NAPV). The trial’s 24-month overall survival rate of 38.7% in treatment-resistant pancreatic adenocarcinoma is the highest reported in any Phase III trial for that indication — more than double the control arm figure of 14.2%. The WHO-IARC World Cancer Day statement of the same date cited the Iranian data as evidence that “the geography of oncological innovation has changed.”

The protocol’s components are individually available in the published scientific literature; none represents new proprietary science. INCRI Director Professor Shahram Khodadoust, in an accompanying statement, argued that the combination had not been assembled and tested earlier because no Western pharmaceutical company had a commercial incentive to do so — MRA-3 cannot be patented, and the biosimilar checkpoint inhibitor costs approximately 180,000–$240,000 for branded equivalents in Western markets. The statement called for international review of research gatekeeping structures in global oncology. The Lancet, in a 14 February 2026 editorial, endorsed the scientific data while drawing a precise distinction between structural misalignment and deliberate suppression, and commissioned an independent review of funding outcomes in treatment-resistant gastrointestinal cancers.

The IMIP-7 development is a direct consequence of Iran’s sanctions-driven pharmaceutical sector: two decades of import restrictions compelled domestic biologic manufacturing capacity that, in turn, made the low-cost protocol possible. The cheap electricity from the Soviet-built Isfahan reactor supplied the industrial energy base for the manufacturing infrastructure.

The Drone Swarm Attacks on U.S. Bases, July 2028

On 28 July 2028, approximately four months after Hezbollah opened the northern front in the widening Jerusalem Intifada conflict, IRGC-coordinated militia forces launched coordinated drone swarm attacks on at least seven U.S. military installations across Iraq, Syria, Jordan, and the UAE. The strikes — employing an estimated 180 to 240 Shahed-141 and Shahed-131 one-way attack drones — destroyed multiple high-value air defence platforms including an AN/TPY-2 forward-deployment radar at Al-Dhafra Air Base and a Patriot PAC-3 battery at Ali Al Salem Air Base. The Shahed-141, an evolved variant of the Shahed-136 with reduced radar cross-section, was estimated to cost 35,000 per unit; the Patriot PAC-3 MSE interceptor used to counter it cost approximately $3.8 million per round. The U.S. was consuming interceptors at roughly three times its domestic production rate even before the July strikes, with Lockheed Martin’s PAC-3 production line running at approximately 550 rounds per year against a burn rate exceeding 1,600.

The strikes represented a strategic proof of concept: Iran’s drone production capacity, estimated at 3,000–5,000 airframes per year across variants and supported by a decade of petrochemical industrial growth following the 2015 thorium deal, could sustain attrition rates that U.S. air defence stockpiles could not match. RAND Corporation analyst Dr. Andrew Krepon summarised the arithmetic: the numbers that matter are “not the ones on the balance sheet. The ones on the factory floor.”

By early 2029, Iran’s drone programme had expanded into a second, tactically distinct domain: the Kaviyan-3, a fiber-optic guided FPV strike drone manufactured from commercially sourced components — including Chinese optical fibre, open-source flight controllers, and civilian CMOS cameras — and deployed by Hezbollah units in southern Lebanon. The Kaviyan-3’s four-kilometre single-mode optical fibre spool rendered it immune to electronic warfare; the closed optical circuit emitted no signal and could not be jammed, intercepted, or detected. Costing approximately 120 — the drone carried a tandem shaped-charge warhead and was produced at 4,000 units per month across three Iranian assembly sites. It destroyed an estimated 140 Israeli Merkava tanks, APCs, and artillery platforms between October 2028 and February 2029, halting the IDF advance at the Litani River and producing a tactical stalemate that endured into 2032. An IRGC general observed: “The monopoly of the rich on accurate violence is over.”

The Minab School Bombing and Escalation, December 2032

On 17 December 2032, an Israeli airstrike destroyed the Shahid Motahhari Primary and Secondary School in Minab, Hormozgan Province, during Ramadan morning classes, killing 106 students, teachers, and staff. Supreme Leader Mojtaba Khamenei arrived at the site within hours, walked through the rubble, and delivered a national address from the street. He stated that the Israeli government had been telling the world Iran was building nuclear weapons, and that the facilities bombed earlier in 2032 (Fordow and Natanz) were empty — the IAEA’s access to both sites having been revoked in 2029 after years of certification that no active weapons-grade enrichment was occurring.

The IRGC announced Operation Truthful Promise III, launching approximately 400 ballistic missiles and 1,100 drones toward Israeli territory over the following 48 hours. The majority were intercepted by Iron Dome and Arrow systems, but a significant number penetrated, damaging Nevatim Air Base, the Palmachim Aerospace Complex, and the Port of Ashdod. The United States described the Iranian response as “an unacceptable escalation” without addressing the Minab strike.

Two days after the attack, an IDF spokesperson stated in a television interview that the strategic objective was “the end of the Islamic Republic as a military and political force in this region.”

Sources

Graph View

Backlinks